
中东和非洲肝癌诊断市场预测至 2028 年 – COVID-19 影响和分析 – 按类型(实验室测试、内窥镜检查、成像、活检等)和最终用户(医院和诊断实验室、学术和研究)研究所和 CRO 实验室)
No. of Pages: 130 | Report Code: BMIRE00025042 | Category: Life Sciences
No. of Pages: 130 | Report Code: BMIRE00025042 | Category: Life Sciences
早期发现和监测肿瘤可以提供更有效的治疗。护理点 (POC) 测试允许患者进行手持式测试,快速给出结果。此外,不需要专业知识或特殊知识,这在资源匮乏地区进行时至关重要。肝细胞癌(HCC)是最常见的恶性肿瘤之一,生存率很低。随着对癌症生物学和技术进步的了解不断加深,我们能够识别出许多驱动肝癌发生的病理、遗传和分子事件,从而发现了这种疾病的许多潜在生物标志物。
< /p>
用于肝癌的一些生物标志物包括甲胎蛋白 (AFP)、Glypican-3、Des-Gamma-Carboxy(异常)凝血酶原 (DCP)、Gamma-谷氨酰转移酶和血清 Alpha -1-岩藻糖苷酶等。大量生物标志物已被证明具有潜在的预测意义。因此,这一因素将在预计期间为肝癌诊断市场提供巨大机遇。
借助新功能和技术,供应商可以吸引新客户并扩大其在新兴市场的足迹。这一因素可能会推动中东和中东地区的发展。非洲肝癌诊断市场在预测期内复合年增长率可观。
中东和中东地区非洲肝癌诊断市场细分
中东和非洲根据类型、最终用户和国家对非洲肝癌诊断市场进行分析。根据类型,市场分为实验室测试、成像、内窥镜检查、活检等。 2021年,实验室测试领域占据最大市场份额,成像领域预计在预测期内将实现更高的复合年增长率。
根据实验室测试,市场分为血液测试和生物标志物。 2021年,血液检测细分市场占有更大的市场份额,预计该细分市场在预测期内的复合年增长率最高。
< p>根据最终用户,市场分为医院和诊断实验室、学术和研究机构以及 CRO 实验室。 2021年,医院和诊断实验室细分市场占据最大市场份额,预计该细分市场在预测期内将实现更高的复合年增长率。
基于国家、中东和地区非洲肝癌诊断市场分为沙特阿拉伯、南非、阿联酋和中东和非洲其他地区。 2021年,沙特阿拉伯占据最大的市场份额,预计在预测期内将以最快的复合年增长率增长。
雅培;生物梅里埃公司; F. 霍夫曼拉罗什有限公司;照明公司;皇家飞利浦公司;凯杰;西门子医疗股份公司;赛默飞世尔科技有限公司;通用电气医疗保健;和 Perspectum 是中东和非洲地区的领先公司。非洲肝癌诊断市场。
Strategic insights for Middle East & Africa Liver Cancer Diagnostics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 382.25 Million |
Market Size by 2028 | US$ 575.86 Million |
Global CAGR (2021 - 2028) | 6.0% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 类型
|
Regions and Countries Covered | 中东和非洲
|
Market leaders and key company profiles |
The regional scope of Middle East & Africa Liver Cancer Diagnostics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Middle East & Africa Liver Cancer Diagnostics Market is valued at US$ 382.25 Million in 2021, it is projected to reach US$ 575.86 Million by 2028.
As per our report Middle East & Africa Liver Cancer Diagnostics Market, the market size is valued at US$ 382.25 Million in 2021, projecting it to reach US$ 575.86 Million by 2028. This translates to a CAGR of approximately 6.0% during the forecast period.
The Middle East & Africa Liver Cancer Diagnostics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Liver Cancer Diagnostics Market report:
The Middle East & Africa Liver Cancer Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East & Africa Liver Cancer Diagnostics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East & Africa Liver Cancer Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.